Trials / Active Not Recruiting
Active Not RecruitingNCT06493578
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo.
A Randomized, Double-Blind, Vehicle-Controlled Phase 2b Trial Evaluating the Efficacy, Safety & Pharmacokinetics of VYN201 Gel in the Treatment of Non Segmental Vitiligo
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Vyne Therapeutics Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of VYN201 Gel in subjects with non-segmental vitiligo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | VYN201 Gel | VYN201 Gel is a topical formulation applied as a thin layer to affected areas. |
| DRUG | Vehicle Gel | Vehicle gel (placebo) is matching in appearance to VYN201 gel and is to be applied in the same manner as VYN201 gel. |
Timeline
- Start date
- 2024-06-04
- Primary completion
- 2025-07-10
- Completion
- 2026-01-30
- First posted
- 2024-07-10
- Last updated
- 2025-09-16
Locations
49 sites across 2 countries: United States, Canada
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06493578. Inclusion in this directory is not an endorsement.